Bengaluru-based Strides Consumer forays into eastern India with two new products
Kolkata/IBNS: Bengaluru-based consumer health care company, Strides Consumer Private Limited (SCPL), recently entered the market in eastern India with two new products.
The two products launched are NIXIT, an oral Nicotine Replacement Therapy (NRT), and JOINTFLEX, a topical analgesic cream for joints.
An NRT gum, NIXIT is available at two price points -- Rs 49 for 2mg for light smokers and Rs 55 for 4mg for heavy smokers.
NRT is a recommended first line therapy by the World Health Organisation (WHO) and US Food and Drug Administration (USFDA) to help people quit smoking.
Currently, the NRT market is around Rs 156 crore and is expected to reach upto Rs 450 crore by 2023 according to industry experts.
The topical anagesic cream JOINTFLEX contains two ingredients, Glucosamine and Chondroitin Sulphate, which help in providing relief from long lasting pain in the joints.
According to the company, JOINTFLEX has been in use in the US for over 20 years.
It comes in two packs - 15g which costs Rs 65 and 30g which costs Rs 120.
The company, which began its journey in 2017, has two marquee investors - India Life Science Fund and Strides Pharma Science Limited.
Chief Executive Officer Subodh Marwah, with over two decades of experience, is leading the business.
(Reported by Harshal Shah)
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
